Accelerate research with a direct connection to patients
Access Evidation’s highly engaged health community to effectively recruit for your trials, engage patients over time, and go to market faster.
Trial Recruitment and Experience
Understand patients’ experiences and unmet needs to reduce burden and increase retention through an ongoing connection to patients
Quickly test hypotheses with digital measures and fast responses from an engaged health community
Accelerate enrollment into your trials by recruiting from a well-characterized, engaged, and research-motivated community
Meet your diversity goals with access to 97% of U.S. zip codes and social determinants of health data
Generating Real-World Evidence
Quantify health and quality of life outcomes with longitudinal data collected directly from patients, including validated ePROs and objective digital measures
Demonstrate value at every stage of treatment development through a deeper understanding of the patient experience, unmet needs, and underserved groups
Differentiate treatment value and support stakeholder decisions with evidence aligned to emerging drivers of market value
Publish peer-reviewed communications to increase treatment consideration and shape clinical guidelines with data collected through prospective, longitudinal real-world studies
Commercial Planning
Build more robust patient journeys with longitudinal surveys, validated ePROs, and digital measures
Increase access by uncovering patient journey barriers and opportunities to intervene outside of traditional care settings
Respond to questions faster with access to our responsive, well-characterized community
Boost marketing effectiveness with more nuanced segmentation based on real-world measures
Prioritize investment decisions with a deeper understanding of what’s actually driving patient behavior and outcomes in everyday life
Solutions we offer for life sciences companies:
Evidation partners include nine of the top 10 biopharma companies in the world, as well as insurers, health systems, technology companies, academia, professional societies, and government agencies.
